FDG-PET in gynaecological cancers: Recent observations

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 11, 2008, Pages 2133-2139

  Lucignani, Giovanni ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GYNECOLOGIC CANCER; HUMAN; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; UNITED STATES; UTERUS CANCER; VULVA CANCER; WHOLE BODY SCINTISCANNING;

FEMALE; FLUORODEOXYGLUCOSE F18; GENITAL NEOPLASMS, FEMALE; HUMANS; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; UTERINE NEOPLASMS;

EID: 53649095891     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0929-4     Document Type: Review

References (21)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 2 74 108
2. AM Stroup LC Harlan EL Trimble 2008 Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States Gynecol Oncol 108 3 577 583
3. RB Iyer A Balachandran CE Devine 2007 PET/CT and cross sectional imaging of gynecologic malignancy Cancer Imaging 7 Spec No A S130 S138
4. CM Huang 2008 Human papillomavirus and vaccination Mayo Clin Proc 83 6 701 706
5. LS Downs JS Smith I Scarinci L Flowers G Parham 2008 The disparity of cervical cancer in diverse populations Gynecol Oncol 109 2 Suppl S22 S30
6. A Loft AK Berthelsen H Roed C Ottosen L Lundvall J Knudsen 2007 The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study Gynecol Oncol 106 1 29 34
7. TC Yen LC See CH Lai CS Tsai A Chao S Hsueh 2008 Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer Eur J Nucl Med Mol Imaging 35 3 493 501
8. M Bjurberg E Kjellén T Ohlsson M Ridderheim E Brun 2007 FDG-PET in cervical cancer: staging, re-staging and follow-up Acta Obstet Gynecol Scand 86 11 1385 1391
9. 18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area J Clin Oncol 26 15 2558 2561
10. Y Yildirim S Sehirali ME Avci C Yilmaz K Ertopcu S Tinar 2008 Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings Gynecol Oncol 108 1 154 159
11. Kitajima K, Murakami K, Yamasaki E, Domeki Y, Kaji Y, Sugimura K. Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer. Eur Radiol. 2008 doi: 10.1007/s00330-008-0979-9
12. JI Sorosky 2008 Endometrial cancer Obstet Gynecol 111 2 Pt 1 436 447
13. R Suzuki E Miyagi N Takahashi A Sukegawa A Suzuki I Koike 2007 Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer Int J Gynecol Cancer 17 4 890 896
14. K Kitajima K Murakami E Yamasaki S Hagiwara I Fukasawa N Inaba 2008 Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer Ann Nucl Med 22 2 103 109
15. JY Park EN Kim DY Kim DS Suh JH Kim YM Kim 2008 Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer Gynecol Oncol 108 3 486 492
16. 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer AJR Am J Roentgenol 190 6 1652 1858
17. F Salehi L Dunfield KP Phillips D Krewski BC Vanderhyden 2008 Risk factors for ovarian cancer: an overview with emphasis on hormonal factors J Toxicol Environ Health B Crit Rev 11 3-4 301 321
18. S Sebastian SI Lee NS Horowitz JA Scott AJ Fischman JF Simeone 2008 PET-CT vs. CT alone in ovarian cancer recurrence Abdom Imaging 33 1 112 118
19. M Soussan M Wartski P Cherel E Fourme A Goupil E Le Stanc 2008 Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence Gynecol Oncol 108 1 160 165
20. CK Kim BK Park JY Choi BG Kim H Han 2007 Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT J Comput Assist Tomogr 31 6 868 875
21. K Kitajima K Murakami E Yamasaki Y Domeki Y Kaji I Fukasawa 2008 Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast- enhanced CT and enhanced CT Eur J Nucl Med Mol Imaging 35 8 1439 1448